Arkolith/Insider Trading/CMPX/Form 4

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER, DirectorCompass Therapeutics, Inc. (CMPX) · full profile →Form 4 · filed May 27, 2025
Net Buying
Open-Market Buys
$21K
Open-Market Sells
$0
Net Open-Market Flow
$21K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 27, 2025Buy(P)10K$2.11$21K6.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-25-003462) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML